Medicine and Dentistry
Dosimetry
100%
Absorbed Dose
82%
Therapeutic Procedure
62%
Radioimmunotherapy
52%
Radioisotope
52%
Extracorporeal
45%
Patient
41%
Prostate Cancer
40%
Radionuclide Therapy
36%
Single-Photon Emission Computed Tomography
34%
Immunoabsorption
34%
Organ
30%
Iodine 125
26%
Injection
25%
Iodine 131
25%
Blood
25%
Technetium-99
24%
Cells
22%
Testes
20%
Irradiation
19%
Combination Therapy
17%
Particle Therapy
17%
Bone Marrow
16%
Xenograft
16%
Liver
15%
Monte Carlo Method
14%
Nuclear Medicine
13%
Therapeutics
13%
Development
13%
Measurement
13%
Positron Emission Tomography
13%
B-Cell Lymphoma
12%
Platelet
12%
Drug Megadose
11%
Nanoparticle
11%
Clinical Dosimetry
11%
Human
10%
Ex Vivo
9%
Americium 241
8%
Radiosensitivity
8%
Iodine 124
7%
Quantitative Imaging
7%
Treatment Planning
7%
Neuroendocrine Tumor
7%
Metabolic Rate
6%
Positron Emission Tomography - Magnetic Resonance Imaging
6%
Carcinoembryonic Antigen
6%
Tumor Cell
6%
Disease
6%
Breast Cancer
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
83%
Radioisotope
70%
Dosimetry
58%
Lutetium 177
55%
Indium 111
43%
Antibodies
35%
Peptide
23%
Radiopharmaceutical Agent
23%
Receptor
21%
Yttrium 90
21%
Pharmacokinetics
20%
Biodistribution
20%
Technetium 99m
20%
B Cell Lymphoma
18%
Iodine-131
18%
Malignant Neoplasm
17%
Nephrotoxicity
17%
Autoradiography
16%
Toxicity
14%
Colon Carcinoma
13%
Gamma Ray
12%
Rat Model
11%
Endotoxin
11%
Recombinant
10%
Antioxidant
10%
Radioligand
8%
Irradiation
8%
Primate
8%
Kidney Injury
7%
Blood Toxicity
7%
Chemotherapy
6%
Castration Resistant Prostate Cancer
6%
Mouse Model
5%
Actinium 225
5%
Inhalation
5%
Bear
5%
Glucose
5%
Prostate Specific Antigen
5%
Cell Death
5%
Sulfur 35
5%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
5%
Maximum Tolerated Dose
5%
Ibritumomab Tiuxetan
5%
Alpha 1 Microglobulin
5%
Synapsin I
5%